litlas
Log inCreate account

Bertrand Coiffier

Active 1989–2019

144
Papers
52,129
Citations
111
h-index
144
i10-index

Citations

Citations per year for Bertrand Coiffier1983: 1 citations1984: 1 citations1985: 8 citations1986: 4 citations1987: 5 citations1988: 2 citations1989: 6 citations1990: 6 citations1991: 7 citations1992: 9 citations1993: 18 citations1994: 38 citations1995: 38 citations1996: 29 citations1997: 77 citations1998: 101 citations1999: 63 citations2000: 128 citations2001: 143 citations2002: 169 citations2003: 274 citations2004: 219 citations2005: 269 citations2006: 289 citations2007: 319 citations2008: 361 citations2009: 300 citations2010: 355 citations2011: 414 citations2012: 399 citations2013: 370 citations2014: 402 citations2015: 436 citations2016: 333 citations2017: 399 citations2018: 303 citations2019: 1,150 citations2020: 1,059 citations2021: 958 citations2022: 620 citations2023: 397 citations2024: 604 citations2025: 208 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,459 citing papers, 25% of this breakdownFrance: 1,035 citing papers, 7.5% of this breakdownItaly: 931 citing papers, 6.7% of this breakdownGermany: 907 citing papers, 6.6% of this breakdownUnited Kingdom: 906 citing papers, 6.6% of this breakdownChina: 736 citing papers, 5.3% of this breakdownSpain: 555 citing papers, 4% of this breakdownCanada: 549 citing papers, 4% of this breakdownSwitzerland: 486 citing papers, 3.5% of this breakdownNetherlands: 380 citing papers, 2.7% of this breakdownJapan: 378 citing papers, 2.7% of this breakdownAustralia: 355 citing papers, 2.6% of this breakdown
0%25%Other 22.8%

Institutions

Fields

  • Medicine85.5%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Immunology and Microbiology3.8%
  • Mathematics0.2%
  • Computer Science0.2%
  • Materials Science0.2%
  • Other0.8%

Topics

  • Lymphoma Diagnosis and Treatment21.1%
  • Chronic Lymphocytic Leukemia Research7.2%
  • CNS Lymphoma Diagnosis and Treatment5.8%
  • Viral-associated cancers and disorders5.4%
  • CAR-T cell therapy research5.4%
  • Cutaneous lymphoproliferative disorders research3.1%
  • Other52%

Coauthors

All papers

Open in search
  1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Authors: Bertrand Coiffier, Éric Lepage, Josette Brière, Raoul Herbrecht, Hervé Tilly, Réda Bouabdallah, Pierre Morel, Éric Van Den Neste, Gilles Salles, Philippe Gaulard, Félix Reyes, P Lederlin, Christian Gisselbrecht - New England Journal of Medicine 2002 cited by 5,562

  2. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

    Authors: Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste, G. Lepeu, Isabelle Plantier, Sylvie Castaigné, Sophie Lefort, Gérald Marit, Margaret Macro, Catherine Sebban, Karim Belhadj, Dominique Bordessoule, Christophe Fermé, Hervé Tilly - Blood 2010 cited by 1,558

  3. Revised Response Criteria for Malignant Lymphoma

    Authors: Bruce D. Cheson, Beate Pfistner, Malik E. Juweid, Randy D. Gascoyne, Lena Specht, Sandra J. Horning, Bertrand Coiffier, Richard I. Fisher, Anton Hagenbeek, Emanuele Zucca, Steven T. Rosen, Sigrid Stroobants, T. Andrew Lister, Richard T. Hoppe, Martin Dreyling, Kensei Tobinai, Julie M. Vose, Joseph M. Connors, Massimo Federico, Volker Diehl - Journal of Clinical Oncology 2007 cited by 4,448

  4. Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

    Authors: Richard R. Furman, Jeff P. Sharman, Steven Coutré, Bruce D. Cheson, John M. Pagel, Peter Hillmen, Jacqueline C. Barrientos, Andrew D. Zelenetz, Thomas J. Kipps, Ian W. Flinn, Paolo Ghia, Herbert Eradat, Thomas J. Ervin, Nicole Lamanna, Bertrand Coiffier, Andrew R. Pettitt, Shuo Ma, Stephan Stilgenbauer, Paula Cramer, Maria Aiello, Dave M. Johnson, Langdon L. Miller, Daniel Li, Thomas M. Jahn, Roger Dansey, Michael Hallek, Susan O’Brien - New England Journal of Medicine 2014 cited by 1,684

  5. Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

    Authors: Bertrand Coiffier, Barbara Pro, H. Miles Prince, Francine M. Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Peter Borchmann, Franck Morschhauser, Martin Wilhelm, Lauren Pinter‐Brown, Swaminathan P. Iyer, Andrei R. Shustov, Jean Nichols, Susan Carroll, John Balser, Barbara Balser, Sarah McCue Horwitz - Journal of Clinical Oncology 2012 cited by 674

  6. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

    Authors: Thierry Philip, Cesare Guglielmi, Anton Hagenbeek, Renier Somers, Hans van der Lelie, Dominique Bron, Pieter Sonneveld, Christian Gisselbrecht, Jean‐Yves Cahn, J L Harousseau, Bertrand Coiffier, Pierre Biron, F Mandelli, Franck Chauvin - New England Journal of Medicine 1995 cited by 2,443

  7. Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

    Authors: Owen A. O’Connor, Barbara Pro, Lauren Pinter‐Brown, Nancy L. Bartlett, Leslie Popplewell, Bertrand Coiffier, Mary Jo Lechowicz, Kerry J. Savage, Andrei R. Shustov, Christian Gisselbrecht, Eric D. Jacobsen, Pier Luigi Zinzani, Richard R. Furman, André Goy, Corinne Haïoun, Michael Crump, Jasmine Zain, Eric D. Hsi, Adam P. Boyd, Steven M. Horwitz - Journal of Clinical Oncology 2011 cited by 643

  8. Diffuse large B-cell lymphoma: R-CHOP failure—what to do?

    Authors: Bertrand Coiffier, Clémentine Sarkozy - Hematology 2016 cited by 290

  9. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    Authors: Pierre Feugier, Ambro van Hoof, Catherine Sebban, P. Solal-Céligny, Réda Bouabdallah, Christophe Fermé, B. Christian, Éric Lepage, Hervé Tilly, Franck Morschhauser, Philippe Gaulard, Gilles Salles, André Bosly, Christian Gisselbrecht, F Reyes, Bertrand Coiffier - Journal of Clinical Oncology 2005 cited by 1,499

  10. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

    Authors: Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont, Antoine Thyss, Jean‐François Emile, Sylvie Castaigné, Bertrand Coiffier, Corinne Haïoun, Serge Bologna, Olivier Fitoussi, G. Lepeu, Christophe Fruchart, Dominique Bordessoule, Michel Blanc, Richard Delarue, Maud Janvier, Bruno César Corrêa Salles, Marc André, Marion Fournier, Philippe Gaulard, Hervé Tilly - The Lancet Oncology 2011 cited by 545

  11. Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia

    Authors: Jeff P. Sharman, Steven Coutré, Richard R. Furman, Bruce D. Cheson, John M. Pagel, Peter Hillmen, Jacqueline C. Barrientos, Andrew D. Zelenetz, Thomas J. Kipps, Ian W. Flinn, Paolo Ghia, Herbert Eradat, Thomas J. Ervin, Nicole Lamanna, Bertrand Coiffier, Andrew R. Pettitt, Shuo Ma, Eugen Tausch, Paula Cramer, Julie Huang, Siddhartha Mitra, Michael Hallek, Susan O’Brien, Stephan Stilgenbauer - Journal of Clinical Oncology 2019 cited by 221

  12. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

    Authors: Gilles Salles, John F. Seymour, Fritz Offner, Armando López‐Guillermo, David Belada, Luc Xerri, Pierre Feugier, Réda Bouabdallah, John Catalano, Pauline Brice, Dolores Caballero, Corinne Haïoun, Lars Møller Pedersen, Alain Delmer, David Simpson, Sirpa Leppä, Pierre Soubeyran, Anton Hagenbeek, Olivier Casasnovas, Tanin Intragumtornchai, Christophe Fermé, María Gomes da Silva, Catherine Sebban, Andrew Lister, Jane Estell, Giuseppe Milone, Anne Sonet, Myriam Mendila, Bertrand Coiffier, Hervé Tilly - The Lancet 2010 cited by 1,066

  13. Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Authors: Catherine Thiéblemont, Hervé Tilly, María Gomes da Silva, Olivier Casasnovas, Christophe Fruchart, Franck Morschhauser, Corinne Haïoun, Julien Lazarovici, Anida Grosicka, Aurore Perrot, Judith Trotman, Catherine Sebban, Dolores Caballero, Richard Greil, Koen Van Eygen, Amos Cohen, Hugo González, Réda Bouabdallah, Lucie Obéric, Bernadette Corront, Bachra Choufi, Armando López‐Guillermo, John Catalano, Achiel Van Hoof, Josette Brière, José Cabeçadas, Gilles Salles, Philippe Gaulard, André Bosly, Bertrand Coiffier - Journal of Clinical Oncology 2017 cited by 195

  14. Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

    Authors: Bertrand Coiffier, Arnold J. Altman, Ching‐Hon Pui, Anas Younes, Mitchell S. Cairo - Journal of Clinical Oncology 2008 cited by 781

  15. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

    Authors: Anas Younes, Patrick Hilden, Bertrand Coiffier, Anton Hagenbeek, Gilles Salles, Wyndham H. Wilson, John F. Seymour, Kara M. Kelly, John G. Gribben, M. Pfreunschuh, Franck Morschhauser, Heiko Schöder, Andrew D. Zelenetz, Jürgen Rademaker, Ranjana H. Advani, Nancy Valente, Catherine Fortpied, Thomas E. Witzig, Laurie H. Sehn, Andreas Engert, Richard I. Fisher, Pier Luigi Zinzani, Massimo Federico, Martin Hutchings, Catherine M. Bollard, Marek Trněný, Yusri Elsayed, Kensei Tobinai, Jeremy S. Abramson, Nathan Fowler, André Goy, Mitchell R. Smith, Stephen M. Ansell, John Kuruvilla, Martin Dreyling, Catherine Thiéblemont, Richard F. Little, Igor Aurer, Marinus H. J. van Oers, Kenichi Takeshita, Ajay K. Gopal, Simon Rule, Sven de Vos, Ioana Kloos, Mark Kaminski, Michel Meignan, Lawrence H. Schwartz, John P. Leonard, Stephen J. Schuster, Venkatraman Seshan - Annals of Oncology 2017 cited by 377

  16. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

    Authors: Christian Récher, Bertrand Coiffier, Corinne Haïoun, Thierry Jo Molina, Christophe Fermé, Olivier Casasnovas, Catherine Thiéblemont, André Bosly, Guy Laurent, Franck Morschhauser, Hervé Ghesquières, Fabrice Jardin, Serge Bologna, Christophe Fruchart, Bernadette Corront, Jean Gabarre, Christophe Bonnet, Maud Janvier, Danielle Canioni, Jean‐Philippe Jaïs, Gilles Salles, Hervé Tilly - The Lancet 2011 cited by 357

  17. Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

    Authors: Andrew D. Zelenetz, Jacqueline C. Barrientos, Jennifer R Brown, Bertrand Coiffier, Julio Delgado, Miklós Egyed, Paolo Ghia, Árpád Illés, Wojciech Jurczak, Paula Marlton, Marco Montillo, Franck Morschhauser, Alexander Pristupa, Tadeusz Robak, Jeff P. Sharman, David Simpson, Lukáš Smolej, Eugen Tausch, Adeboye H. Adewoye, Lyndah Dreiling, Yeonhee Kim, Stephan Stilgenbauer, Peter Hillmen - The Lancet Oncology 2017 cited by 247

  18. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

    Authors: Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, Vittoria Tarantino, Martina Manni, Clémentine Sarkozy, Sara Alonso, Mariëlle J. Wondergem, Guillaume Cartron, Armando López‐Guillermo, Djamila E. Issa, Franck Morschhauser, Miguel Alcoceba, Eva Kimby, Chiara Rusconi, Martine E.D. Chamuleau, Harald Holte, Sandra Lockmer, Silvia Montoto, María Gomes da Silva, Igor Aurer, Emanuele Zucca, Ewa Paszkiewicz‐Kozik, Carla Minoia, Tetiana Skrypets, Yngvild Nuvin Blaker, Gilles Salles, Bertrand Coiffier - The Lancet Haematology 2018 cited by 116

  19. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

    Authors: Eva Hoster, Andreas Rosenwald, Françoise Berger, Heinz‐Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Stephan Stilgenbauer, Roswitha Forstpointner, Catherine Thiéblemont, Michael Hallek, Bertrand Coiffier, Ursula Vehling‐Kaiser, Réda Bouabdallah, Lothar Kanz, Michael Pfreundschuh, Christian Schmidt, Vincent Ribrag, Wolfgang Hiddemann, Michael Unterhalt, Johanna C. Kluin-Nelemans, Olivier Hermine, Martin Dreyling, Wolfgang Hiddemann - Journal of Clinical Oncology 2016 cited by 362

  20. Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

    Authors: Bertrand Coiffier, Barbara Pro, H. Miles Prince, Francine M. Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Franck Morschhauser, Martin Wilhelm, Lauren Pinter‐Brown, Swaminathan P. Iyer, Andrei R. Shustov, Tina Nielsen, Jean Nichols, Julie Wolfson, Barbara Balser, Sarah McCue Horwitz - Journal of Hematology & Oncology 2014 cited by 209

  21. Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

    Authors: Vincent Ribrag, Won Seog Kim, Réda Bouabdallah, Soon Thye Lim, Bertrand Coiffier, Árpád Illés, Bernard Lemieux, Martin J.S. Dyer, Fritz Offner, Zakia Felloussi, Ioana Kloos, Ying Luan, Remus Vezan, Thorsten Graef, Franck Morschhauser - Haematologica 2017 cited by 97

  22. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus

    Authors: Mitchell S. Cairo, Bertrand Coiffier, Alfred Reiter, Anas Younes, on behalf of the TLS Expert Panel - British Journal of Haematology 2010 cited by 558

  23. Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project

    Authors: Massimo Federico, Thomas Rüdiger, Monica Bellei, Bharat N. Nathwani, Stefano Luminari, Bertrand Coiffier, Nancy L. Harris, Elaine S. Jaffe, Stefano Pileri, Kerry J. Savage, Dennis D. Weisenburger, Jamés O. Armitage, Nicholas Mounier, Julie M. Vose - Journal of Clinical Oncology 2012 cited by 361

  24. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

    Authors: Jan Delabie, Harald Holte, Julie M. Vose, Fred Ullrich, Elaine S. Jaffe, Kerry J. Savage, Joseph M. Connors, Lisa M. Rimsza, Nancy L. Harris, Konrad Müller-Hermelink, Thomas Rüdiger, Bertrand Coiffier, Randy D. Gascoyne, Françoise Berger, Kensei Tobinai, Wing Y. Au, Raymond Liang, Emili Montserrat, Ephraim P. Hochberg, Stefano Pileri, Massimo Federico, Bharat N. Nathwani, Jamés O. Armitage, Dennis D. Weisenburger - Blood 2011 cited by 360